Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2012

May 1, 2012

29819_dirs_2012-05-01_9494d91f-e10a-4cb9-a017-63c46cea658e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-04-27

Reporting Person: Dittrich Thomas J.W. (VP, Finance & CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-27 Common Stock A 1400 Acquired 14025 Direct
2012-04-28 Common Stock F 78 $71.64 Disposed 13947 Direct
2012-04-29 Common Stock F 233 $71.64 Disposed 13714 Direct

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2: The shares include the following RSUs granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.